The purpose of this study is to determine the effectiveness of different doses of epoetin alfa for treating anemia in patients who have cancer; or patients who no longer have any signs of cancer, but remain anemic as a result of their treatment. These patients should not be currently receiving chemotherapy or radiotherapy. A subject's participation in the study will last approximately 6 months. Subjects will receive weekly doses of epoetin alfa or placebo. Their hemoglobin will be tested every week.
Study Type
INTERVENTIONAL
Purpose
TREATMENT
Heritage Physician Group-Oncology
Hot Springs, Arkansas, United States
Spalding Oncology Services
Griffin, Georgia, United States
Southern Illinois Hematology
Centralia, Illinois, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
BioLab Research
Rockville, Maryland, United States
Slocum-Dickson Medical Group, PC
New Hartford, New York, United States
NorthEast Urology Research
Concord, North Carolina, United States
Mid Ohio Oncology Hematology
Columbus, Ohio, United States
Drexel University College of Medicine
Philadelphia, Pennsylvania, United States
Caroline Cancer Center
Aiken, South Carolina, United States
Charleston Hematology Oncology
Charleston, South Carolina, United States
...and 2 more locations